Return to homepagePandemic Pact

Task V12: CLINICAL SAMPLE TESTING FOR ZIKA VIRUS VACCINES

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 272201800013I-0-759302200001-1

Grant search

Key facts

  • Disease

    Zika virus disease

  • Start & end year

    2022
    2022

  • Known Financial Commitments (USD)

    $211,025

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    THOMAS RUDGE

  • Research Location

    United States of America

  • Lead Research Institution

    BATTELLE CENTERS/PUB HLTH RES & EVALUATN

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through activities required for the submission of Biologic License Application (BLA) and/or Investigational New Drug (IND) applications.